Breast tumors may also be categorized as Luminal A, Luminal B (HER2+ and HER2-), HER2+ (often “HER2-enriched”), and ER-/PR-/HER2- (“triple-negative”) subtypes, with, in general, progressively worse prognosis in this order [46-48]. Here, ERBB2 is linked to breast neoplasm.